Wafa Guetari

Myocardial Infarction in a Young Patient with Chronic Myeloid Leukemia after Nilotinib Use

Neila Fathallah, Kmira Zahra, Rania Bouneb, Mohamed Mahjoub, Wafa Guetari, Monia Zaier, Chaker Ben Salem & Abderrahim Khelif · International Journal of Medical and Pharmaceutical Case Reports · 2016

Nilotinib is an analog of imatinib increasingly used for the treatment of imatinib-resistant chronic myeloid leukemia. It has been considered a well-tolerated drug with little side effects. The most common adverse effects to nilotinib are skin rash, pruritus, headache, nausea, an...